WHO SMART Guidelines - HIV
0.4.3 - ci-build

WHO SMART Guidelines - HIV - Local Development build (v0.4.3) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: HIV.IND.14 Logic - XML Representation

Draft as of 2025-02-07

Raw xml | Download


<Library xmlns="http://hl7.org/fhir">
  <id value="HIVIND14Logic"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"/>
    <profile
             value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"/>
    <profile
             value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"/>
    <profile
             value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
<div>
    <table class="grid dict">
        
        
        <tr>
            <th scope="row"><b>Title: </b></th>
            <td style="padding-left: 4px;">HIV.IND.14 Logic</td>
        </tr>
        

        
        
        <tr>
            <th scope="row"><b>Id: </b></th>
            <td style="padding-left: 4px;">HIVIND14Logic</td>
        </tr>
        

        
        
        <tr>
            <th scope="row"><b>Version: </b></th>
            <td style="padding-left: 4px;">0.4.3</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Url: </b></th>
            <td style="padding-left: 4px;"><a href="Library-HIVIND14Logic.html">HIV.IND.14 Logic</a></td>
        </tr>
        

        

        

        
        <tr>
            <th scope="row"><b>Status: </b></th>
            <td style="padding-left: 4px;">draft</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Experimental: </b></th>
            <td style="padding-left: 4px;">true</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Type: </b></th>
            <td style="padding-left: 4px;">
                
                    
                        
                        <p style="margin-bottom: 5px;">
                            <b>system: </b> <span><a href="http://terminology.hl7.org/6.0.2/CodeSystem-library-type.html">http://terminology.hl7.org/CodeSystem/library-type</a></span>
                        </p>
                        
                        
                        <p style="margin-bottom: 5px;">
                            <b>code: </b> <span>logic-library</span>
                        </p>
                        
                        
                    
                
                
            </td>
        </tr>
        

        

        
        <tr>
            <th scope="row"><b>Date: </b></th>
            <td style="padding-left: 4px;">2025-02-07 14:15:45+0000</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Publisher: </b></th>
            <td style="padding-left: 4px;">WHO</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Description: </b></th>
            <td style="padding-left: 4px;"><div><p>% of OAMT recipients receiving a maintenance dose greater than or equal to the recommended minimum dose</p>
</div></td>
        </tr>
        

        

        

        

        

        

        

        

        

        

        

        

        

        

        
        
        <tr>
          <td colspan="2">
            <table>
              <tr><th><a id="cql-content"><b>Content: </b></a> text/cql</th></tr>
              <tr><td><pre><code class="language-cql">/**
 * Library: HIV.IND.14 Logic
 * Ref No: PRV.14
 * Short Name: OAMT minimum dose
 *
 * Definition: % of OAMT recipients receiving a maintenance dose greater than or equal to the recommended minimum dose
 *
 * Numerator: Number of people, at a specified date, maintained on methadone or buprenorphine receiving recommended minimum maintenance dose (WHO guidance recommends doses of ≥60 mg of methadone or ≥8 mg of buprenorphine*)
 * Numerator Calculation: COUNT of clients with (&quot;Medications prescribed&quot;='Methadone' AND &quot;Dose of medications prescribed&quot; GREATER THAN OR EQUAL TO 60mg) OR (&quot;Medications prescribed&quot;='Buprenorphine' AND &quot;Dose of medications prescribed&quot; GREATER THAN OR EQUAL TO 8mg) for a specified &quot;Reporting date&quot;
 * Numerator Exclusions: &quot;Client being inducted on OAMT&quot; OR &quot;Client on reducing doses of OAMT&quot;
 *
 * Denominator: Number of people receiving maintenance dose of methadone or buprenorphine at a specified date, excluding: a) individuals currently being inducted on OAMT and yet to reach the maintenance dose and b) individuals on reducing doses of OAMT.
 * Denominator Calculation: COUNT of clients with &quot;Medications prescribed&quot; IN 'Methadone', 'Buprenorphine' for a specified &quot;Reporting date&quot;
 * Denominator Exclusions: &quot;Client being inducted on OAMT&quot; OR &quot;Client on reducing doses of OAMT&quot;
 *
 * Disaggregations:
 * • Gender (female, male, other**) 
 *  • Age (15–19, 20–24, 25–49, 50+ years) 
 *  • Provider type (key population-led or community-led organization, public sector provider, other entities such as private for-profit and not-for-profit organizations, including faith-based, international, nongovernmental) 
 *  • Setting: facility-based service (including hospitals, health clinics, general practice offices, etc.) or community-based service (including drop-in centres, community service delivery points, mobile clinics or vans, outreach teams, community support groups, etc.) 
 *  • Cities and other administrative regions of epidemiologic importance
 *
 * Disaggregation Elements: Gender | Age
 *
 * Numerator and Denominator Elements:
 * Dose of medications prescribed 
 *  Medications prescribed 
 *  Reporting date
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.C.DE75: Medications prescribed | Medications the client was prescribed
 * HIV.C.DE76: PrEP for HIV prevention | Client was prescribed pre-exposure prophylaxis (PrEP) for HIV prevention
 * HIV.C.DE77: PEP for HIV prevention | Client was prescribed post-exposure prophylaxis (PEP) for HIV prevention
 * HIV.C.DE78: Other | Client was prescribed other medications
 * HIV.D.DE457: Medications prescribed | Name or regimen code of all other medications prescribed during the visit
 * HIV.D.DE459: Dose of medications prescribed | Number of doses (quantity taken at a single point in time) of drugs prescribed/dispensed
 * HIV.Config.DE22: Reporting date | Reporting date, for surveys performed on a specific date
 *
 * Additional Context
 * - what it measures: Measures the proportion of OAMT recipients receiving the recommended minimum maintenance dose.
 * - rationale: Evidence demonstrates that maximum benefit from OAMT is gained when individuals receive at least the recommended minimum maintenance dose.
 * - method: Individual-level data obtained from programme records
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 
 * Profiles: HivTreatmentMedicationRequest, HivOamtEpisodeOfCare
 */

library HIVIND14Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include WHOCommon called WCom

include HIVIndicatorElements called HIE
include HIVElements called HE

// Indicator Definition
parameter &quot;Measurement Period&quot; Interval&lt;Date&gt; default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define &quot;Initial Population&quot;:
  true

/**
 * Numerator
 * 
 * Definition: Number of people, at a specified date, maintained on methadone or buprenorphine receiving recommended minimum maintenance dose (WHO guidance recommends doses of ≥60 mg of methadone or ≥8 mg of buprenorphine*)
 * Calculation: COUNT of clients with (&quot;Medications prescribed&quot;='Methadone' AND &quot;Dose of medications prescribed&quot; GREATER THAN OR EQUAL TO 60mg) OR (&quot;Medications prescribed&quot;='Buprenorphine' AND &quot;Dose of medications prescribed&quot; GREATER THAN OR EQUAL TO 8mg) for a specified &quot;Reporting date&quot;
 */

define &quot;Numerator&quot;:
  First(HIE.&quot;Methadone D.DE555&quot;).dailyDose() &gt;= System.Quantity{ value: 60, unit: 'mg' }
  or First(HIE.&quot;Buprenorphine D.DE552&quot;).dailyDose() &gt;= System.Quantity{ value: 8, unit: 'mg' }

/**
 * Numerator Exclusions
 *
 * Calculation: &quot;Client being inducted on OAMT&quot; OR &quot;Client on reducing doses of OAMT&quot;
 */
    
define &quot;Numerator Exclusions&quot;:
  HIE.&quot;Client being inducted on OAMT&quot; or HIE.&quot;Client on reducing doses of OAMT&quot;

/**
 * Denominator
 *
 * Definition: Number of people receiving maintenance dose of methadone or buprenorphine at a specified date, excluding: a) individuals currently being inducted on OAMT and yet to reach the maintenance dose and b) individuals on reducing doses of OAMT.
 * Calculation: COUNT of clients with &quot;Medications prescribed&quot; IN 'Methadone', 'Buprenorphine' for a specified &quot;Reporting date&quot;
 */

define &quot;Denominator&quot;:
  Exists(HIE.&quot;Methadone D.DE555&quot;) or Exists(HIE.&quot;Buprenorphine D.DE552&quot;)
    
/**
* Denominator Exclusions
*
* Calculation: &quot;Client being inducted on OAMT&quot; OR &quot;Client on reducing doses of OAMT&quot;
*/

define &quot;Denominator Exclusions&quot;:
  HIE.&quot;Client being inducted on OAMT&quot; or HIE.&quot;Client on reducing doses of OAMT&quot;

/* end Populations */


/*
 * Disaggregators
 */

define &quot;Administrative Gender Stratifier&quot;:
	HIE.&quot;By Administrative Gender Stratifier&quot;

define &quot;Age Stratifier&quot;:
	HIE.&quot;By Age Stratifier 3&quot;

define &quot;Geographic Region Stratifier&quot;:
	HIE.&quot;By Geographic Region Stratifier&quot;

define &quot;Setting&quot;:
    HIE.&quot;setting&quot;

//provider type not provided?

define &quot;Stratification&quot;:
 HIE.&quot;By Administrative Gender Stratifier&quot;.code 
  + ':' + HIE.&quot;By Age Stratifier 3&quot;
+ ':' + HIE.&quot;By Geographic Region Stratifier&quot;
 + ':' + HIE.&quot;setting&quot;.code</code></pre></td></tr>
            </table>
          </td>
        </tr>
        
        
        
    </table>
</div>
</div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <url value="http://smart.who.int/hiv/Library/HIVIND14Logic"/>
  <version value="0.4.3"/>
  <name value="HIVIND14Logic"/>
  <title value="HIV.IND.14 Logic"/>
  <status value="draft"/>
  <experimental value="true"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/library-type"/>
      <code value="logic-library"/>
    </coding>
  </type>
  <date value="2025-02-07T14:15:45+00:00"/>
  <publisher value="WHO"/>
  <contact>
    <name value="WHO"/>
    <telecom>
      <system value="url"/>
      <value value="http://who.int"/>
    </telecom>
  </contact>
  <description
               value="% of OAMT recipients receiving a maintenance dose greater than or equal to the recommended minimum dose"/>
  <content>
    <contentType value="text/cql"/>
    <data
          value="/**
 * Library: HIV.IND.14 Logic
 * Ref No: PRV.14
 * Short Name: OAMT minimum dose
 *
 * Definition: % of OAMT recipients receiving a maintenance dose greater than or equal to the recommended minimum dose
 *
 * Numerator: Number of people, at a specified date, maintained on methadone or buprenorphine receiving recommended minimum maintenance dose (WHO guidance recommends doses of ≥60 mg of methadone or ≥8 mg of buprenorphine*)
 * Numerator Calculation: COUNT of clients with ("Medications prescribed"='Methadone' AND "Dose of medications prescribed" GREATER THAN OR EQUAL TO 60mg) OR ("Medications prescribed"='Buprenorphine' AND "Dose of medications prescribed" GREATER THAN OR EQUAL TO 8mg) for a specified "Reporting date"
 * Numerator Exclusions: "Client being inducted on OAMT" OR "Client on reducing doses of OAMT"
 *
 * Denominator: Number of people receiving maintenance dose of methadone or buprenorphine at a specified date, excluding: a) individuals currently being inducted on OAMT and yet to reach the maintenance dose and b) individuals on reducing doses of OAMT.
 * Denominator Calculation: COUNT of clients with "Medications prescribed" IN 'Methadone', 'Buprenorphine' for a specified "Reporting date"
 * Denominator Exclusions: "Client being inducted on OAMT" OR "Client on reducing doses of OAMT"
 *
 * Disaggregations:
 * • Gender (female, male, other**) 
 *  • Age (15–19, 20–24, 25–49, 50+ years) 
 *  • Provider type (key population-led or community-led organization, public sector provider, other entities such as private for-profit and not-for-profit organizations, including faith-based, international, nongovernmental) 
 *  • Setting: facility-based service (including hospitals, health clinics, general practice offices, etc.) or community-based service (including drop-in centres, community service delivery points, mobile clinics or vans, outreach teams, community support groups, etc.) 
 *  • Cities and other administrative regions of epidemiologic importance
 *
 * Disaggregation Elements: Gender | Age
 *
 * Numerator and Denominator Elements:
 * Dose of medications prescribed 
 *  Medications prescribed 
 *  Reporting date
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.C.DE75: Medications prescribed | Medications the client was prescribed
 * HIV.C.DE76: PrEP for HIV prevention | Client was prescribed pre-exposure prophylaxis (PrEP) for HIV prevention
 * HIV.C.DE77: PEP for HIV prevention | Client was prescribed post-exposure prophylaxis (PEP) for HIV prevention
 * HIV.C.DE78: Other | Client was prescribed other medications
 * HIV.D.DE457: Medications prescribed | Name or regimen code of all other medications prescribed during the visit
 * HIV.D.DE459: Dose of medications prescribed | Number of doses (quantity taken at a single point in time) of drugs prescribed/dispensed
 * HIV.Config.DE22: Reporting date | Reporting date, for surveys performed on a specific date
 *
 * Additional Context
 * - what it measures: Measures the proportion of OAMT recipients receiving the recommended minimum maintenance dose.
 * - rationale: Evidence demonstrates that maximum benefit from OAMT is gained when individuals receive at least the recommended minimum maintenance dose.
 * - method: Individual-level data obtained from programme records
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 
 * Profiles: HivTreatmentMedicationRequest, HivOamtEpisodeOfCare
 */

library HIVIND14Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include WHOCommon called WCom

include HIVIndicatorElements called HIE
include HIVElements called HE

// Indicator Definition
parameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define "Initial Population":
  true

/**
 * Numerator
 * 
 * Definition: Number of people, at a specified date, maintained on methadone or buprenorphine receiving recommended minimum maintenance dose (WHO guidance recommends doses of ≥60 mg of methadone or ≥8 mg of buprenorphine*)
 * Calculation: COUNT of clients with ("Medications prescribed"='Methadone' AND "Dose of medications prescribed" GREATER THAN OR EQUAL TO 60mg) OR ("Medications prescribed"='Buprenorphine' AND "Dose of medications prescribed" GREATER THAN OR EQUAL TO 8mg) for a specified "Reporting date"
 */

define "Numerator":
  First(HIE."Methadone D.DE555").dailyDose() >= System.Quantity{ value: 60, unit: 'mg' }
  or First(HIE."Buprenorphine D.DE552").dailyDose() >= System.Quantity{ value: 8, unit: 'mg' }

/**
 * Numerator Exclusions
 *
 * Calculation: "Client being inducted on OAMT" OR "Client on reducing doses of OAMT"
 */
    
define "Numerator Exclusions":
  HIE."Client being inducted on OAMT" or HIE."Client on reducing doses of OAMT"

/**
 * Denominator
 *
 * Definition: Number of people receiving maintenance dose of methadone or buprenorphine at a specified date, excluding: a) individuals currently being inducted on OAMT and yet to reach the maintenance dose and b) individuals on reducing doses of OAMT.
 * Calculation: COUNT of clients with "Medications prescribed" IN 'Methadone', 'Buprenorphine' for a specified "Reporting date"
 */

define "Denominator":
  Exists(HIE."Methadone D.DE555") or Exists(HIE."Buprenorphine D.DE552")
    
/**
* Denominator Exclusions
*
* Calculation: "Client being inducted on OAMT" OR "Client on reducing doses of OAMT"
*/

define "Denominator Exclusions":
  HIE."Client being inducted on OAMT" or HIE."Client on reducing doses of OAMT"

/* end Populations */


/*
 * Disaggregators
 */

define "Administrative Gender Stratifier":
	HIE."By Administrative Gender Stratifier"

define "Age Stratifier":
	HIE."By Age Stratifier 3"

define "Geographic Region Stratifier":
	HIE."By Geographic Region Stratifier"

define "Setting":
    HIE."setting"

//provider type not provided?

define "Stratification":
 HIE."By Administrative Gender Stratifier".code 
  + ':' + HIE."By Age Stratifier 3"
+ ':' + HIE."By Geographic Region Stratifier"
 + ':' + HIE."setting".code"/>
  </content>
</Library>